XYNOMIC PHARMACEUTICALS INC has a total of 11 patent applications. Its first patent ever was published in 2018. It filed its patents most often in Australia, Brazil and Canada. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are BEIJING LUNARSUN PHARMACEUTICAL CO LTD, VERTEX PHARMACEUTICALS EUROPE LTD and CRYSTAL PHARMACEUTICAL SUZHOU CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 1 | |
#2 | Brazil | 1 | |
#3 | Canada | 1 | |
#4 | China | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Israel | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Philippines | 1 | |
#9 | Singapore | 1 | |
#10 | United States | 1 | |
#11 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Organic chemistry methods | |
#3 | Medical preparations | |
#4 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Betzemeier Bodo | 9 |
#2 | Schaaf Otmar | 9 |
#3 | Werthmann Ulrike | 9 |
#4 | Maier Gerd-Michael | 8 |
#5 | Gerd-Michael Maier | 1 |
#6 | Maier Gerd Michael | 1 |
#7 | Ulrike Werthmann | 1 |
#8 | Bodo Betzemeier | 1 |
#9 | Otmar Schaaf | 1 |
Publication | Filing date | Title |
---|---|---|
KR20200088345A | Crystalline salt of B-RAF kinase inhibitor |